SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-17-000433
Filing Date
2017-01-23
Accepted
2017-01-23 17:14:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM S-3 vtgns3_jan2017.htm S-3 467046
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-2.htm EX-23.2 3663
3 IMAGE vistagen.jpg GRAPHIC 9859
  Complete submission text file 0001654954-17-000433.txt   485485
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-215671 | Film No.: 17541659
SIC: 2834 Pharmaceutical Preparations